Titan Biotech Shares Surge After Supply Split
Shares of biological product supplier Titan Biotech experienced a 20 % rise, getting to 312 on February 20, following a 1: 5 stock split. The split, announced in November, aimed to increase liquidity and attract retail financiers.
- Supply Split: The 1: 5 split increased exceptional shares fivefold, changing the price to 260 per share.
- Financial Efficiency: Q 3 FY 26 saw a web profit of 8 53 crore, up from 4 39 crore year-over-year, with earnings increasing 47 6 % to 56 51 crore.
- Shareholding: Promoters hold 55 8 % of the risk, while retail capitalists hold 44 2 %.